State Street’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,324,061
| Closed | -$128M | – | 3852 |
|
|
2019
Q3 | $128M | Buy |
1,324,061
+19,736
| +2% | +$1.98M | 0.01% | 864 |
|
|
2019
Q2 | $134M | Buy |
1,304,325
+283,521
| +28% | +$30.6M | 0.01% | 869 |
|
|
2019
Q1 | $116M | Sell |
1,020,804
-799,194
| -44% | -$58.7M | 0.01% | 919 |
|
|
2018
Q4 | $71.2M | Buy |
1,819,998
+17,934
| +1% | +$778K | 0.01% | 1120 |
|
|
2018
Q3 | $98.3M | Buy |
1,802,064
+304,272
| +20% | +$20.8M | 0.01% | 1090 |
|
|
2018
Q2 | $124M | Sell |
1,497,792
-278,573
| -16% | -$21.5M | 0.01% | 897 |
|
|
2018
Q1 | $118M | Buy |
1,776,365
+377,801
| +27% | +$21.8M | 0.01% | 915 |
|
|
2017
Q4 | $71.9M | Buy |
1,398,564
+204,238
| +17% | +$14.7M | 0.01% | 1211 |
|
|
2017
Q3 | $106M | Buy |
1,194,326
+357,746
| +43% | +$27.2M | 0.01% | 948 |
|
|
2017
Q2 | $50M | Sell |
836,580
-46,146
| -5% | -$2.58M | ﹤0.01% | 1351 |
|
|
2017
Q1 | $47.1M | Sell |
882,726
-19,880
| -2% | -$1.18M | ﹤0.01% | 1362 |
|
|
2016
Q4 | $45M | Buy |
902,606
+99,792
| +12% | +$5.35M | ﹤0.01% | 1332 |
|
|
2016
Q3 | $48.2M | Buy |
802,814
+326,018
| +68% | +$18.8M | ﹤0.01% | 1232 |
|
|
2016
Q2 | $24.4M | Buy |
476,796
+45,084
| +10% | +$1.93M | ﹤0.01% | 1613 |
|
|
2016
Q1 | $12.7M | Sell |
431,712
-55,159
| -11% | -$1.74M | ﹤0.01% | 2024 |
|
|
2015
Q4 | $22.1M | Sell |
486,871
-185,584
| -28% | -$9.73M | ﹤0.01% | 1647 |
|
|
2015
Q3 | $28.1M | Buy |
672,455
+186,057
| +38% | +$9.71M | ﹤0.01% | 1517 |
|
|
2015
Q2 | $29.3M | Buy |
486,398
+416,699
| +598% | +$27.6M | ﹤0.01% | 1596 |
|
|
2015
Q1 | $5.41M | Buy |
+69,699
| New | +$4.01M | ﹤0.01% | 2525 |
|
State Street's ONCE Position: Q4 2019 in Review
State Street sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 1,324,061 shares — an estimated $128M sold.
State Street first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $134M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- State Street reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- State Street sold 1,324,061 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $128M.
- State Street first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
- State Street's Spark Therapeutics, Inc. Common Stock position peaked at $134M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on State Street's 13F filing for Q4 2019, filed 6 Feb 2020.